Kanguva USA Advance Box Office Update: Suriya’s mystical action-drama NEEDS a big spike in bookings for good day 1
Kanguva Pre-Sales Kick Off in the USA with Strong Start – 3,800 Tickets Sold
Kanguva is scheduled for a theatrical release on November 14th, and early reports indicate good anticipation in advance sales overseas. In the U.S., pre-sales were recently opened, and as of 10 AM IST on November 8, around 3,800 tickets were sold, generating USD 83,000.
Advance bookings were launched in over 400 U.S. locations, with Kanguva slated to screen across roughly 1,080 shows. The initial response is promising for the Suriya starrer, though it will need to build on this momentum over the next six days to maximize pre-release hype.
The film is poised for a wide global release. However, to make a strong debut at the box office and capitalize on the buzz, a significant boost in ticket sales is needed.
Kanguva Prepares for a Blockbuster Opening Across India
Directed by Siva, Kanguva has already generated excitement among audiences in India, suggesting the potential for a powerful opening. Once advance bookings start in Indian theaters, we’ll have a clearer picture of its opening day prospects. For now, the film is on track to be Suriya’s biggest opening to date.
In addition to Suriya, the cast includes Bobby Deol and Disha Patani in important roles. Produced by Studio Green, this high-budget film is positioned as a groundbreaking addition to Tamil cinema.
Can Kanguva Overcome the Success of Amaran at the Box Office?
One challenge ahead for Kanguva is its competition with Amaran, a hit featuring Sivakarthikeyan and Sai Pallavi. If Kanguva receives strong word-of-mouth and appeals to the Hindi-speaking market, it has immense box office potential.
In keeping with recent trends, Kanguva is designed as a two-part story. Bobby Deol plays the main antagonist in the first part, and it remains to be seen whether his character will carry over to the second film or if a new villain will be introduced.
